• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Human Research Protection Program

University of Southern CaliforniaResearch and Innovation
  • Getting Started
  • Research
  • HRPP
  • IRB
  • Education & Certification
  • Policies
  • Contact
You are here: Home / Research / Emergency Research

Emergency Research

Planned Emergency Research

FDA regulations allow certain planned emergency research to be undertaken when the intervention or interaction will be used on subjects unable to provide consent because of the emergency situation. A novel mechanism called “community consultation” must be utilized to alert the relevant community of this planned research before the IRB can give final approval. The regulations require consultation with representatives of (and public disclosure to) the communities in which the clinical investigation will be conducted and from which the subjects will be drawn, prior to initiation of the clinical investigation. The conditions required to conduct this type of research with exception from informed consent are described in 21 CFR 50.24. and detailed in USC Human Research Protection Program Policies and Procedures.

FDA Guidance on Exceptions from Informed Consent

Emergency Use of a Test Article (Investigational Drug, Biologic or Device)

FDA regulations provide for use of a test article in a human subject in a life-threatening situation in which no standard acceptable treatment is available and in which there is not sufficient time to obtain IRB approval (21 CFR 56.104(c)). Refer to USC HRPP.

Individual Emergency Use of an Investigational Drug, Biologic

The emergency use of an unapproved investigational drug or biologic requires an IND. The need for an investigational drug or biologic may arise in an emergency situation that does not allow time for submission of an IND. In such a case, FDA may authorize shipment of the test article for treatment of an individual in advance of the IND submission. (21 CFR part 312, subpart I)

Individual Expanded Access Involving Investigational New Drug

Footer

HRPP

3720 S. Flower Street, Suite 325
Los Angeles, CA 90089

HRPP@usc.edu
(323) 442-0114

Full Accreditation badge from the Association for the Accreditation of Human Research Protection Programs

About Us

  • Home
  • Announcements
  • Contact
  • Getting Started
  • Education & Certification
  • HRPP
  • Policies
  • Twitter

Research

  • BioIRB Meeting Dates
  • BioIRB Rosters
  • Biomedical Research
  • Biospecimen & Data Repositories
  • Emergency Research
  • Investigational Drugs and Devices
  • Investigator-Initiated Trials
  • Reliance Agreements
  • Requesting USC IRB to Act as the sIRB
  • Requesting USC to Rely on an External IRB
  • SBIRB Meeting Dates
  • SBIRB Roster
  • SBIRB Social Behavioral Research
  • Starting a Research Trial: the Basics
  • Student Researchers

IRB

  • Forms and Templates
  • FWA and IRB Registration Numbers
  • IRB FAQs
  • IRB Review: How to
  • IRB Submission Guidelines
  • Levels of IRB Review
  • Not Human Subjects Research (NHSR)
  • Privacy, Confidentiality, and Anonymity in Human Subjects Research
  • Recruitment Guidance
  • Urgent Review

HRPP
3720 S. Flower Street, Suite 325
Los Angeles, CA 90089
oprs@usc.edu
irb@usc.edu
(323) 442-0114

Full Accreditation badge from the Association for the Accreditation of Human Research Protection Programs
University of Southern California   Content managed by HRPP
  • Privacy Notice - Notice of Non-Discrimination